The Scripps Research Institute

Ending speculations about deliberate genetic engineering of new coronavirus, scientists from the Scripps Research Institute, a non-profit research organization, have claimed that the COVID-19 pandemic is not from a lab-created virus but has a natural origin.

In a path-breaking experiment, scientists at theThe Scripps Research Institute (TSRI) in the United States have discovered a way to make cells resistant to the HIV virus.

A recent study at The Scripps Research Institute (TSRI) shows that holes in HIV's defensive sugar shield could be important in designing an HIV vaccine.

Scientists are developing a new AIDS vaccine capable of inducing naturally produced antibodies in HIV patients to prevent the deadly infection.

Scientists have identified a fat molecule in brain cells that may act as a 'switch' to increase or decrease the motivation to consume nicotine, a finding that could lead to new therapies to help smokers kick the butt.

Experts from The Scripps Research Institute (TSRI), Mayo Clinic and other institutions have coined the term 'senolytics' for the new class of drugs that were tested in animal models to slow down the ageing process.

Ending speculations about deliberate genetic engineering of new coronavirus, scientists from the Scripps Research Institute, a non-profit research organization, have claimed that the COVID-19 pandemic is not from a lab-created virus but has a natural origin.

In a path-breaking experiment, scientists at theThe Scripps Research Institute (TSRI) in the United States have discovered a way to make cells resistant to the HIV virus.

A recent study at The Scripps Research Institute (TSRI) shows that holes in HIV's defensive sugar shield could be important in designing an HIV vaccine.

Scientists are developing a new AIDS vaccine capable of inducing naturally produced antibodies in HIV patients to prevent the deadly infection.

Scientists have identified a fat molecule in brain cells that may act as a 'switch' to increase or decrease the motivation to consume nicotine, a finding that could lead to new therapies to help smokers kick the butt.

Experts from The Scripps Research Institute (TSRI), Mayo Clinic and other institutions have coined the term 'senolytics' for the new class of drugs that were tested in animal models to slow down the ageing process.